OpenAI's life-sciences model GPT-6 Rosalind is open only to approved research organizations, through separate access routes
Use in Work and Codex and use through the API need separate approvals, and the release documents include no comparative performance data.

OpenAI released GPT-6 Rosalind on October 30. The company describes it as bringing specialized biological reasoning and scientific tool use to complex life-sciences research. The model is not available to every OpenAI workspace. According to an analysis by Forkast, the API changelog identifies the model as gpt-6-rosalind and limits access to organizations approved for Rosalind Research through OpenAI's trusted-access program, for internal research by authorized users. Help Center documentation says approved Research organizations can use the model in Work and Codex, that API access needs a separate approval, and that the model is not offered in the Chat tab. Forkast says teams also need to tell Research access apart from Discovery access, and internal use apart from customer-facing products, because approval for one route does not carry over to another. The outlet notes that the release documents contain no comparative performance data, so it cannot yet be shown whether Rosalind beats existing systems. For research operations leaders and people building workflows, Forkast argues that the immediate question is less about capability than about who may use the model, through which route, and for what work. The gated design reflects the dual-use concerns that surround capable biology models.